KCM
PFE icon

Kanawha Capital Management’s Pfizer PFE Stock Holding History

Kanawha Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.16M Buy
290,585
+25,442
+10% +$677K 0.58% 52
2025
Q4 		$6.6M Sell
265,143
-13,533
-5% -$341K 0.45% 61
2025
Q3 		$7.1M Sell
278,676
-4,423
-2% -$109K 0.49% 58
2025
Q2 		$6.86M Buy
283,099
+8,664
+3% +$202K 0.51% 57
2025
Q1 		$6.95M Buy
274,435
+24,026
+10% +$629K 0.54% 55
2024
Q4 		$6.64M Sell
250,409
-28,918
-10% -$784K 0.52% 54
2024
Q3 		$8.08M Buy
279,327
+8,975
+3% +$262K 0.59% 52
2024
Q2 		$7.56M Buy
270,352
+9,300
+4% +$256K 0.59% 52
2024
Q1 		$7.24M Buy
261,052
+38,126
+17% +$1.06M 0.58% 52
2023
Q4 		$6.42M Sell
222,926
-24,138
-10% -$730K 0.59% 54
2023
Q3 		$8.2M Buy
247,064
+2,628
+1% +$92.9K 0.79% 37
2023
Q2 		$8.97M Buy
244,436
+1,552
+0.6% +$60.4K 0.82% 36
2023
Q1 		$9.91M Buy
242,884
+4,655
+2% +$201K 0.95% 33
2022
Q4 		$12.2M Sell
238,229
-4,125
-2% -$198K 1.2% 27
2022
Q3 		$10.6M Sell
242,354
-4,515
-2% -$219K 1.16% 30
2022
Q2 		$12.9M Buy
246,869
+675
+0.3% +$34.4K 1.31% 29
2022
Q1 		$12.7M Buy
246,194
+8,351
+4% +$433K 1.12% 31
2021
Q4 		$14M Buy
237,843
+1,177
+0.5% +$58.3K 1.19% 30
2021
Q3 		$10.2M Buy
236,666
+1,060
+0.4% +$47K 0.94% 37
2021
Q2 		$9.23M Buy
235,606
+2,270
+1% +$88.3K 0.85% 45
2021
Q1 		$8.45M Buy
233,336
+5,682
+2% +$202K 0.82% 45
2020
Q4 		$8.38M Sell
227,654
-10,714
-4% -$393K 0.86% 43
2020
Q3 		$8.3M Buy
238,368
+3,603
+2% +$126K 0.95% 36
2020
Q2 		$7.28M Buy
234,765
+2,094
+0.9% +$71.1K 0.9% 40
2020
Q1 		$7.21M Buy
232,671
+7,727
+3% +$263K 1.05% 33
2019
Q4 		$8.36M Buy
224,944
+18,313
+9% +$652K 0.98% 39
2019
Q3 		$7.04M Buy
206,631
+7,595
+4% +$276K 0.92% 41
2019
Q2 		$8.18M Buy
199,036
+5,770
+3% +$229K 1.1% 36
2019
Q1 		$7.79M Sell
193,266
-3,206
-2% -$128K 1.09% 35
2018
Q4 		$8.14M Buy
196,472
+1,557
+0.8% +$64.6K 1.27% 31
2018
Q3 		$8.15M Buy
194,915
+332
+0.2% +$12.8K 1.13% 35
2018
Q2 		$6.7M Sell
194,583
-1,591
-0.8% -$54.4K 1% 38
2018
Q1 		$6.61M Buy
196,174
+3,388
+2% +$116K 1% 39
2017
Q4 		$6.63M Buy
192,786
+2,247
+1% +$76.6K 0.97% 41
2017
Q3 		$6.45M Sell
190,539
-2,554
-1% -$82.1K 0.99% 42
2017
Q2 		$6.15M Sell
193,093
-3,711
-2% -$117K 0.96% 44
2017
Q1 		$6.39M Buy
196,804
+2,263
+1% +$71.3K 1.02% 42
2016
Q4 		$6M Sell
194,541
-3,151
-2% -$96.2K 1.01% 42
2016
Q3 		$6.35M Buy
197,692
+1,643
+0.8% +$54.9K 1.07% 41
2016
Q2 		$6.55M Sell
196,049
-1,671
-0.8% -$53.3K 1.1% 38
2016
Q1 		$5.56M Buy
197,720
+4,280
+2% +$122K 0.96% 46
2015
Q4 		$5.92M Buy
193,440
+637
+0.3% +$20K 1.06% 38
2015
Q3 		$5.75M Sell
192,803
-2,495
-1% -$80K 1.11% 40
2015
Q2 		$6.21M Sell
195,298
-930
-0.5% -$30.3K 1.1% 39
2015
Q1 		$6.48M Buy
196,228
+2,514
+1% +$79.9K 1.13% 38
2014
Q4 		$5.72M Buy
193,714
+244
+0.1% +$7K 1% 42
2014
Q3 		$5.43M Sell
193,470
-17
-0% -$477 0.99% 43
2014
Q2 		$5.45M Sell
193,487
-652
-0.3% -$18.6K 1% 43
2014
Q1 		$5.92M Sell
194,139
-4,776
-2% -$142K 1.12% 38
2013
Q4 		$5.78M Sell
198,915
-669
-0.3% -$19.5K 1.1% 38
2013
Q3 		$5.44M Buy
199,584
+10,223
+5% +$278K 1.13% 37
2013
Q2 		$5.03M Buy
+189,361
New +$5.23M 1.11% 39

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kanawha Capital Management's PFE Position: Q1 2026 in Review

Kanawha Capital Management increased its Pfizer (PFE) stake by 9.6% in Q1 2026, buying an estimated $677K and bringing the position to 290,585 shares worth $8.16M. The position accounts for 0.58% of the portfolio, ranked #52.

Kanawha Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Kanawha Capital Management held 290,585 shares of Pfizer worth $8.16M as of Q1 2026.
  • Kanawha Capital Management bought 25,442 Pfizer shares in Q1 2026, an estimated $677K.
  • Pfizer made up 0.58% of Kanawha Capital Management's portfolio in Q1 2026, its #52 holding.
  • Kanawha Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Kanawha Capital Management's Pfizer position peaked at $14M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.